PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: 2021 Annual Report and Appendix 4E, page-82

  1. 4,148 Posts.
    lightbulb Created with Sketch. 6629
    In truth WRpar20, there is a lot more to answer you properly and it would warrant some more study. Its far more complex than just a few line here, for example it depends on how the drug binds, what it binds to, absorption rates, the stability of the drug (in our case for example, thankfully, ours is stable at room temperature thus lends itself better to a SubQ route of admin.).

    There are many factors, even maths gets involved here with Log Values...yeh I'd have to read up on that stuff cos it is been more than 30 years since I had to deal with logs...err the maths ones, not the wood ones...

    The other advantage of SubQ for us is that it is easier to self-administer and this becomes more important when it is more than just one or two injections as part of the first course for example.

    - Mozz

    Last edited by Mozzarc: 03/09/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 23.3¢ $111.8K 474.5K

Buyers (Bids)

No. Vol. Price($)
6 154744 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 21128 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
23.5¢
  Change
0.005 ( 2.17 %)
Open High Low Volume
23.5¢ 24.0¢ 23.5¢ 63872
Last updated 15.59pm 14/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.